PPARG and neoplasm: Many studies have revealed that PPARγ acts as a tumor inhibitor, because it is mainly exposed in prostate, breast, and colonic epithelium and the appearance of cultured cancer cell lines suppositious of these tissue types with ligands of PPARγ restrain cellular proliferation [26–31].